1. 274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer. (10th December 2020) Authors: Ascierto, Maria; Hellmann, Matthew; Standifer, Nathan; Wu, Song; Si, Han; Morehouse, Chris; Rebelatto, Marlon; Abdullah, Shaad; Raja, Rajiv; Soria, Jean-Charles; Germa, Caroline; Barrett, Carl Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine. (10th December 2020) Authors: Chow, Andrew; Schad, Sara; Green, Michael; Hellmann, Matthew; Ceglia, Nicholas; Allaj, Viola; Zago, Giulia; Shah, Nisarg; Sharma, Sai; Mattar, Marissa; Chan, Joseph; Rizvi, Hira; Zhong, Hong; Liu, Cailian; Bykov, Yonina; Zamarin, Dmitriy; Shi, Hongyu; Budhu, Sadna; Wohlhieter, Corrin; Uddin, Fathema Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227). Issue 2 (December 2015) Authors: Hellmann, Matthew; Ramalingam, Suresh; Reck, Martin; O'Byrne, Ken; Paz-Ares, Luis; Harbison, Christopher; Bhagavatheeswaran, Prabhu; Nathan, Faith; Brahmer, Julie Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227). (4th November 2015) Authors: Hellmann, Matthew; Ramalingam, Suresh; Reck, Martin; O'Byrne, Ken; Paz-Ares, Luis; Harbison, Christopher T; Bhagavatheeswaran, Prabhu; Nathan, Faith; Brahmer, Julie Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. Issue 1 (26th March 2020) Authors: Merino, Diana M; McShane, Lisa M; Fabrizio, David; Funari, Vincent; Chen, Shu-Jen; White, James R; Wenz, Paul; Baden, Jonathan; Barrett, J Carl; Chaudhary, Ruchi; Chen, Li; Chen, Wangjuh (Sting); Cheng, Jen-Hao; Cyanam, Dinesh; Dickey, Jennifer S; Gupta, Vikas; Hellmann, Matthew; Helman, Elena; L... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma. (2nd January 2016) Authors: Hellmann, Matthew; Rizvi, Naiyer; Wolchok, Jedd D.; Chan, Timothy A. Journal: Molecular & cellular oncology Issue: Volume 3:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Original Article: Non–Small Cell Lung Cancer - Adaptive Neoadjuvant Chemotherapy Guided by 18F-FDG PET in Resectable Non–Small Cell Lung Cancers: The NEOSCAN Trial. Issue 4 (April 2016) Authors: Chaft, Jamie E.; Dunphy, Mark; Naidoo, Jarushka; Travis, William D.; Hellmann, Matthew; Woo, Kaitlin; Downey, Robert; Rusch, Valerie; Ginsberg, Michelle S.; Azzoli, Christopher G.; Kris, Mark G. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Issue 2 (4th August 2020) Authors: Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗